V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20031557 | 20013470 | 1.6 | 64.2 | Adjuvant (A) | 2013-11-14 | 2013-10-22 | FEC 100 + DOCETAXEL | N | N | 20111101 | FEC + DOCETAXEL |
| 20031558 | 20013470 | 1.62 | 77.4 | Adjuvant (A) | 2014-11-14 | 2014-11-28 | FEC 100 + DOCETAXEL | 2 | N | 20111101 | FEC + DOCETAXEL |
| 20031559 | 20013470 | 1.73 | 66.8 | Adjuvant (A) | null | 2017-02-26 | FEC 100 + DOCETAXEL | N | N | 20111101 | FEC + DOCETAXEL |
| 20031560 | 20148140 | 1.62 | 120 | Neo-adjuvant (N) | 2017-12-06 | 2017-12-14 | FEC + DOCETAXEL | N | N | 20111141 | FEC + DOCETAXEL |
| 20031561 | 20013471 | 1.64 | 52 | Neo-adjuvant (N) | 2017-10-05 | 2017-10-21 | FEC 100 + DOCETAXEL | N | null | 20111146 | FEC + DOCETAXEL |
| 20031562 | 20013472 | 1.55 | 82.3 | Not known (9) | 2015-11-26 | 2015-11-28 | FEC + DOCETAXEL | 02 | N | 20111150 | FEC + DOCETAXEL |
| 20031563 | 20013472 | 1.51 | 54 | Adjuvant (A) | 2018-03-12 | 2018-03-15 | FEC 100 + DOCETAXEL | 02 | N | 20111150 | FEC + DOCETAXEL |
| 20031564 | 20013473 | 1.62 | null | Adjuvant (A) | 2016-03-01 | 2016-04-02 | FEC + DOCETAXEL | N | N | 20111156 | FEC + DOCETAXEL |
| 20031565 | 20013473 | 1.38 | 74 | Adjuvant (A) | null | 2017-06-28 | FEC 100 + DOCETAXEL | N | N | 20111156 | FEC + DOCETAXEL |
| 20031566 | 20013473 | null | 82 | Not known (9) | null | 2015-04-10 | FEC + DOCETAXEL | N | N | 20111156 | FEC + DOCETAXEL |
| 20031567 | 20013473 | 1.55 | 55 | Palliative (P) | 2014-09-24 | 2014-10-10 | FEC 100 + DOCETAXEL | 02 | N | 20111156 | FEC + DOCETAXEL |
| 20031568 | 20013473 | 1.61 | 53.2 | Adjuvant (A) | 2013-04-30 | 2013-05-09 | FEC + DOCETAXEL | 02 | N | 20111156 | FEC + DOCETAXEL |
| 20031569 | 20013473 | 1.55 | 76.4 | Adjuvant (A) | 2017-03-15 | 2017-03-29 | FEC + DOCETAXEL | 02 | N | 20111156 | FEC + DOCETAXEL |
| 20031570 | 20013474 | null | null | Adjuvant (A) | 2014-06-15 | 2014-06-15 | FEC 100 + DOCETAXEL | null | null | 20111187 | FEC + DOCETAXEL |
| 20031571 | 20013475 | 1.63 | 51.35 | Neo-adjuvant (N) | 2015-01-19 | 2015-02-09 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20111189 | FEC + DOCETAXEL |
| 20031572 | 20013476 | 1.65 | 78.7 | Adjuvant (A) | 2016-07-20 | 2016-08-16 | FEC 60 OR 75 + DOCETAXEL | N | N | 20111190 | FEC + DOCETAXEL |
| 20031573 | 20013476 | 1.54 | 62.55 | Adjuvant (A) | 2015-11-06 | 2015-12-02 | FEC + DOCETAXEL | 2 | N | 20111190 | FEC + DOCETAXEL |
| 20031574 | 20013476 | 1.61 | 79 | Adjuvant (A) | 2013-11-28 | 2013-12-07 | FEC + DOCETAXEL | 02 | N | 20111190 | FEC + DOCETAXEL |
| 20031575 | 20013476 | 1.63 | 66 | Adjuvant (A) | 2018-01-10 | 2018-01-10 | FEC + DOCETAXEL | 2 | N | 20111190 | FEC + DOCETAXEL |
| 20031576 | 20013476 | 1.65 | 67.8 | Curative (C) | null | 2016-09-18 | FEC + DOCETAXEL | null | N | 20111190 | FEC + DOCETAXEL |
| 20031577 | 20013476 | 1.77 | 97.3 | Not known (9) | 2014-05-09 | 2014-05-10 | FEC + DOCETAXEL | 2 | N | 20111190 | FEC + DOCETAXEL |
| 20031578 | 20013476 | 1.7 | 74.8 | Adjuvant (A) | 2014-02-03 | 2014-02-03 | FEC 100 + DOCETAXEL | 02 | null | 20111190 | FEC + DOCETAXEL |
| 20031579 | 20013477 | 1.68 | 69 | Neo-adjuvant (N) | 2013-06-25 | 2013-07-09 | FEC + DOCETAXEL | 02 | N | 20111214 | FEC + DOCETAXEL |
| 20031580 | 20013477 | 1.52 | 60 | Adjuvant (A) | 2015-03-10 | 2015-03-10 | FEC + DOCETAXEL | 2 | N | 20111214 | FEC + DOCETAXEL |
| 20031581 | 20013478 | 1.74 | 71 | Neo-adjuvant (N) | 2013-11-12 | 2013-11-29 | FEC + DOCETAXEL | N | N | 20111225 | FEC + DOCETAXEL |
| 20031582 | 20013478 | 1.7 | null | Adjuvant (A) | null | 2016-04-13 | FEC + DOCETAXEL | null | null | 20111225 | FEC + DOCETAXEL |
| 20031583 | 20013479 | null | 93.5 | Adjuvant (A) | 2017-10-24 | 2017-10-24 | FEC + DOCETAXEL | 02 | N | 20111241 | FEC + DOCETAXEL |
| 20031584 | 20013479 | null | null | Adjuvant (A) | 2014-08-09 | 2014-08-30 | FEC + DOCETAXEL | N | N | 20111241 | FEC + DOCETAXEL |
| 20031585 | 20013479 | 1.6 | 0 | Adjuvant (A) | 2015-04-22 | 2015-05-10 | FEC + DOCETAXEL | 02 | N | 20111241 | FEC + DOCETAXEL |
| 20031586 | 20013480 | 0 | 103.2 | Adjuvant (A) | 2017-09-23 | 2017-10-11 | FEC + DOCETAXEL | 02 | N | 20111244 | FEC + DOCETAXEL |
| 20031587 | 20013480 | 1.62 | 60 | Adjuvant (A) | 2015-01-29 | 2015-02-12 | FEC + DOCETAXEL | N | N | 20111244 | FEC + DOCETAXEL |
| 20031588 | 20013481 | 1.54 | 98.2 | Adjuvant (A) | 2017-05-30 | 2017-06-03 | FEC + DOCETAXEL | 02 | N | 20111246 | FEC + DOCETAXEL |
| 20031589 | 20013482 | 1.64 | 113.6 | Neo-adjuvant (N) | 2013-08-01 | 2013-08-01 | FEC + DOCETAXEL | 02 | N | 20111249 | FEC + DOCETAXEL |
| 20031590 | 20013483 | null | null | Adjuvant (A) | 2016-02-13 | 2016-02-29 | FEC 100 + DOCETAXEL | N | N | 20111254 | FEC + DOCETAXEL |
| 20031591 | 20013484 | null | 88.7 | Adjuvant (A) | 2015-05-11 | 2015-06-05 | FEC + DOCETAXEL | 2 | N | 20111261 | FEC + DOCETAXEL |
| 20031592 | 20013484 | 1.6 | 71 | Adjuvant (A) | 2015-01-01 | 2015-01-06 | FEC 100 + DOCETAXEL | N | N | 20111261 | FEC + DOCETAXEL |
| 20031593 | 20109435 | 1.54 | 69 | Adjuvant (A) | null | 2017-03-24 | FEC + DOCETAXEL | N | N | 20111265 | FEC + DOCETAXEL |
| 20031594 | 20109435 | 1.65 | 56 | Adjuvant (A) | 2016-01-19 | 2016-01-19 | FEC + DOCETAXEL | 02 | N | 20111265 | FEC + DOCETAXEL |
| 20031595 | 20013485 | 1.6 | 93 | Adjuvant (A) | 2014-10-31 | 2014-11-15 | FEC + DOCETAXEL | 02 | null | 20111269 | FEC + DOCETAXEL |
| 20031596 | 20013485 | 1.81 | 107.4 | Adjuvant (A) | 2018-03-10 | 2018-03-10 | FEC + DOCETAXEL | 2 | N | 20111269 | FEC + DOCETAXEL |
| 20031597 | 20013485 | 1.56 | 72 | Neo-adjuvant (N) | 2017-08-18 | 2017-08-29 | FEC 100 + DOCETAXEL | N | N | 20111269 | FEC + DOCETAXEL |
| 20031598 | 20128208 | null | 71.5 | Neo-adjuvant (N) | 2016-11-08 | 2016-11-21 | FEC 100 + DOCETAXEL | N | N | 20111283 | FEC + DOCETAXEL |
| 20031599 | 20013486 | 1.69 | 119.7 | Adjuvant (A) | 2015-11-16 | 2015-11-17 | FEC 100 + DOCETAXEL | 2 | N | 20111287 | FEC + DOCETAXEL |
| 20031600 | 20013486 | 1.63 | 65 | Neo-adjuvant (N) | 2015-02-08 | 2015-02-11 | FEC + DOCETAXEL | 02 | N | 20111287 | FEC + DOCETAXEL |
| 20031601 | 20013486 | 1.64 | 108.8 | Adjuvant (A) | 2017-07-20 | 2017-07-23 | FEC 100 + DOCETAXEL | 02 | N | 20111287 | FEC + DOCETAXEL |
| 20031602 | 20013486 | 1.63 | 63 | Adjuvant (A) | 2015-03-16 | 2015-03-19 | FEC 100 + DOCETAXEL | 02 | N | 20111287 | FEC + DOCETAXEL |
| 20031603 | 20138010 | 1.54 | 76.6 | Neo-adjuvant (N) | 2015-01-20 | 2015-01-29 | FEC + DOCETAXEL | 02 | N | 20111298 | FEC + DOCETAXEL |
| 20031604 | 20138010 | 1.69 | null | Neo-adjuvant (N) | 2015-09-19 | 2015-10-12 | FEC 100 + DOCETAXEL | N | N | 20111298 | FEC + DOCETAXEL |
| 20031605 | 20138010 | 1.66 | 64.1 | Adjuvant (A) | 2016-01-14 | 2016-01-26 | FEC + DOCETAXEL | 2 | N | 20111298 | FEC + DOCETAXEL |
| 20031606 | 20138010 | null | 64.8 | Adjuvant (A) | 2016-07-20 | 2016-08-05 | FEC + DOCETAXEL | N | N | 20111298 | FEC + DOCETAXEL |